Targeting RNA splicing modulation: new perspectives for anticancer strategy?

X Lv, X Sun, Y Gao, X Song, X Hu, L Gong… - Journal of Experimental …, 2025 - Springer
The excision of introns from pre-mRNA is a crucial process in the expression of the majority
of genes. Alternative splicing allows a single gene to generate diverse mRNA and protein …

Protein arginine methyltransferases as regulators of cellular stress

J Zaccarelli-Magalhães, CT Citadin, J Langman… - Experimental …, 2024 - Elsevier
Arginine modification can be a “switch” to regulate DNA transcription and a post-
translational modification via methylation of a variety of cellular targets involved in signal …

PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma

F Brown-Burke, I Hwang, S Sloan… - Blood …, 2023 - ashpublications.org
Mantle cell lymphoma (MCL) is an incurable B-cell malignancy that comprises up to 6% of
non-Hodgkin lymphomas diagnosed annually and is associated with a poor prognosis. The …

PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH)

F Brown-Burke, R Saadey, HYCC Mao… - Blood …, 2025 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a rare but aggressive and potentially lethal
hyperinflammatory syndrome characterized by pathologic immune activation and excessive …

PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma

JH Liang, WT Wang, R Wang, R Gao, KX Du, ZW Duan… - Cancer Letters, 2024 - Elsevier
Mantle cell lymphoma (MCL) is an incurable and aggressive subtype of non-Hodgkin B-cell
lymphoma. Increased lipid uptake, storage, and lipogenesis occur in a variety of cancers …

Dismantling relapsed/refractory mantle cell lymphoma

CE Ryan, A Kumar - Blood Reviews, 2024 - Elsevier
Despite recent therapeutic advancements in the general field of non-Hodgkin lymphoma,
effective treatment of relapsed or refractory (R/R) mantle cell lymphoma (MCL) remains a …

PIK3IP1: Structure, Aberration, Function, and Regulation in diseases

Y Jia, P He, X Ma, K Lv, Y Liu, Y Xu - European Journal of Pharmacology, 2024 - Elsevier
Abstract Phosphoinositide 3-kinase (PI3K) pathway, controlling diverse functions in cells, is
one of the most frequently dysregulated pathways in cancer. Several negative regulators …

Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells

Y Wang, X Sun, R Ma, X Zhang, S Ji, Z Liu… - Cancer …, 2024 - Wiley Online Library
Background Methylthioadenosine phosphorylase (MTAP) and protein arginine
methyltransferase 5 (PRMT5) are considered to be a synthetic lethal pair of targets, due to …

Chromatin modifiers in human disease: from functional roles to regulatory mechanisms

Y Nie, C Song, H Huang, S Mao, K Ding, H Tang - Molecular Biomedicine, 2024 - Springer
The field of transcriptional regulation has revealed the vital role of chromatin modifiers in
human diseases from the beginning of functional exploration to the process of participating …

SENP3 Promotes Mantle Cell Lymphoma Development through Regulating Wnt10a Expression

Y Ma, Y Zou, Z Liu, G Wu, Y Zhou, C Luo… - Current Medical …, 2024 - Springer
Objective SUMO-specific protease 3 (SENP3), a member of the SUMO-specific protease
family, reverses the SUMOylation of SUMO-2/3 conjugates. Dysregulation of SENP3 has …